Back to Search Start Over

1172PA first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors.

Authors :
Awada, A
Eskens, F A L M
Robbrecht, D G
Lassen, U N
Sorensen, M
Schellens, J H M
Groot, J S de
Jungels, C
Aftimos, P G
Fretland, S O
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133286786
Full Text :
https://doi.org/10.1093/annonc/mdy288.045